✦ LIBER ✦

Incorporating short-term outcome information to predict long-term survival with discrete markers

✍ Scribed by Layla Parast; Su-Chun Cheng; Tianxi Cai

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 263 KB
Volume: 53
Category: Article
ISSN: 0323-3847
DOI: 10.1002/bimj.201000150

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

DOES AGE PREDICT THE LONG-TERM OUTCOME O

DOES AGE PREDICT THE LONG-TERM OUTCOME OF DEPRESSION TREATED WITH ECT? (A PROSPECTIVE STUDY OF THE LONG-TERM OUTCOME OF ECT-TREATED DEPRESSION WITH RESPECT TO AGE)

✍ MICHAEL L. WESSON; ANDREW M. WILKINSON; DAVID N. ANDERSON; CHERIE McCRACKEN 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 2 views

Sixty-three subjects with DSM-III-R major depression with melancholia or psychosis were followed up 2±4 years after index treatment with electroconvulsive therapy. There was a twofold increase in likelihood of improved outcome with an additional 20 years of age.

Visible angiographic complications predi

Visible angiographic complications predict short and long-term outcomes in patients with post-procedural creatine-phosphokinase elevation

✍ Paul Fefer; Amin Daoulah; Bradley H. Strauss; Robert Chisholm; John D. Sparkes; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB 👁 1 views

## Abstract Objectives: To assess whether visible angiographic complication is related to outcome in patients with elevated creatine phosphokinase (CK‐MB) following percutaneous coronary intervention (PCI). Background: Elevated biomarkers following PCI are associated with increased incidence of adv

Long-term results and modeling to predic

Long-term results and modeling to predict outcomes in recipients with HCV infection: Results of the NIDDK liver transplantation database

✍ Michael Charlton; Kris Ruppert; Steven H. Belle; Nathan Bass; Daniel Schafer; Ru 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB 👁 2 views

## Hepatitis C virus (HCV)-associated liver disease is the most common indication for liver transplantation (LT). There are, however, no long-term (>5 year) studies of comparative outcomes for recipients with HCV infection, and no models capable of identifying recipients with HCV infection at great